The Study on Effects of CYP3A and P-glycoprotein Inhibitor Itraconazole and CYP Enzyme Inducer Rifampin of HMPL-453 Tartrate Tablets

Clinical trial NCT07697157 · COMPLETED

Trial details

NCT number: NCT07697157
Sponsor: Hutchmed
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Health, Subjective

Start date: 2025-03-01
Primary completion: 2025-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.